Zepp Health
ZEPP
28 hedge funds and large institutions have $11.8M invested in Zepp Health in 2026 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 12 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
4% less call options, than puts
Call options by funds: $180K | Put options by funds: $187K
13% less funds holding
Funds holding: 32 → 28 (-4)
22.42% less ownership
Funds ownership: 49.11% → 26.69% (-22%)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
72% less capital invested
Capital invested by funds: $41.3M → $11.8M (-$29.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$1.7M |
| 2 |
Morgan Stanley
New York
|
+$357K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$274K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$250K |
| 5 |
AC
AXQ Capital
Jersey City,
New Jersey
|
+$171K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.9M |
| 2 |
Millennium Management
New York
|
-$4.09M |
| 3 |
MM
Monolith Management
Hong Kong
|
-$2.08M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.52M |
| 5 |
Goldman Sachs
New York
|
-$1.41M |
ZEPP Hedge Fund Activity: Q2 2026 in Review
28 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Zepp Health (ZEPP) for Q2 2026, worth a combined $11.8M — down 72% from $41.3M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ZEPP and 8 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 9 added.
The largest buyer was Yiheng Capital Management, adding an estimated $1.7M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $6.9M sold.
- 28 institutional investors held Zepp Health (ZEPP) as of Q2 2026, down from 32 in Q1 2026.
- Funds reported $11.8M of Zepp Health stock for Q2 2026, down 72% quarter-over-quarter.
- 8 funds opened new Zepp Health positions in Q2 2026 and 12 closed out, a net change of -4 holders.
- The largest Zepp Health buyer in Q2 2026 was Yiheng Capital Management, an estimated $1.7M added.
- The largest Zepp Health seller in Q2 2026 was Point72 Asset Management, an estimated $6.9M sold.
Based on aggregated 13F filings for Q2 2026.